Peng Yuan

3.4k total citations · 1 hit paper
148 papers, 2.1k citations indexed

About

Peng Yuan is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Peng Yuan has authored 148 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 56 papers in Cancer Research and 36 papers in Molecular Biology. Recurrent topics in Peng Yuan's work include Cancer Treatment and Pharmacology (41 papers), Breast Cancer Treatment Studies (40 papers) and HER2/EGFR in Cancer Research (33 papers). Peng Yuan is often cited by papers focused on Cancer Treatment and Pharmacology (41 papers), Breast Cancer Treatment Studies (40 papers) and HER2/EGFR in Cancer Research (33 papers). Peng Yuan collaborates with scholars based in China, United States and United Kingdom. Peng Yuan's co-authors include Fei Ma, Binghe Xu, Binghe Xu, Pin Zhang, Juanjuan Ou, Ying Fan, Ruigang Cai, Songlin Gao, Jiayu Wang and Qing Li and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Peng Yuan

136 papers receiving 2.1k citations

Hit Papers

Prediction of HER2-positive breast cancer recurrence and ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning
    2021 158 citations Songlin Gao, Peng Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peng Yuan China 27 951 806 735 392 226 148 2.1k
Maurizio Di Bonito Italy 26 794 0.8× 870 1.1× 736 1.0× 272 0.7× 372 1.6× 82 2.0k
Julia Beretov Australia 25 858 0.9× 1.3k 1.6× 926 1.3× 410 1.0× 207 0.9× 51 2.4k
Lisha Qi China 28 585 0.6× 1.4k 1.7× 893 1.2× 415 1.1× 221 1.0× 71 2.4k
Michael S. Toss United Kingdom 25 854 0.9× 801 1.0× 698 0.9× 281 0.7× 373 1.7× 116 2.0k
Giosuè Scognamiglio Italy 33 1.0k 1.1× 986 1.2× 600 0.8× 291 0.7× 106 0.5× 83 2.3k
Christina Yau United States 28 1.4k 1.5× 1.1k 1.4× 1.2k 1.6× 463 1.2× 237 1.0× 153 2.8k
Pascal Jézéquel France 27 789 0.8× 1.5k 1.8× 663 0.9× 430 1.1× 144 0.6× 64 2.4k
Yan Mao China 23 1.0k 1.1× 839 1.0× 748 1.0× 338 0.9× 110 0.5× 64 2.1k
David A. Quigley United States 25 807 0.8× 1.1k 1.4× 664 0.9× 492 1.3× 116 0.5× 63 2.1k

Countries citing papers authored by Peng Yuan

Since Specialization
Citations

This map shows the geographic impact of Peng Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Yuan more than expected).

Fields of papers citing papers by Peng Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Yuan. The network helps show where Peng Yuan may publish in the future.

Co-authorship network of co-authors of Peng Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Yuan. A scholar is included among the top collaborators of Peng Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Yuan. Peng Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wenming, Hanyong Sun, Peng Yuan, et al.. (2025). Hepatocyte-derived liver progenitor-like cells attenuate liver cirrhosis via induction of apoptosis in hepatic stellate cells. Hepatology Communications. 9(2). 4 indexed citations
3.
Mei, Shanshan, Qunyan Zhou, Wanqing Iris Zhi, et al.. (2025). Characteristics of cardiopulmonary exercise capacity in adults with different degrees of obesity. Frontiers in Physiology. 15. 1466153–1466153. 1 indexed citations
4.
Yuan, Peng, Wenqian Xiong, Hengwei Liu, et al.. (2025). Estradiol Promotes Endometriosis Progression Via the ERβ/QKI /circSMAD2 Axis. Current Pharmaceutical Biotechnology. 26. 1 indexed citations
5.
Jin, Xin, Dandan Zheng, Peng Yuan, et al.. (2025). Disrupted Glucose Metabolism Covariance Network in Amyotrophic Lateral Sclerosis. CNS Neuroscience & Therapeutics. 31(7). e70537–e70537. 1 indexed citations
6.
Wang, Xue, Feng Du, Jian Yue, et al.. (2023). Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer. Cancer Biology and Medicine. 20(2). 155–168. 7 indexed citations
7.
8.
9.
Yuan, Peng, Xun Yao, Jingjing Cui, et al.. (2023). A Machine Learning‐Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2‐Weighted and Diffusion‐Weighted MRI. Journal of Magnetic Resonance Imaging. 60(2). 600–612. 7 indexed citations
10.
Zhang, Wei, Xiwen Wang, Ying Xu, et al.. (2023). Novel Insights into The Roles of N6-methyladenosine (m6A) Modification and Autophagy in Human Diseases. International Journal of Biological Sciences. 19(2). 705–720. 16 indexed citations
11.
Gao, Songlin, Xi Wang, Bo Zhang, et al.. (2022). Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up. Breast Cancer Research and Treatment. 197(3). 569–582. 1 indexed citations
12.
Mo, Hongnan, Fei Ma, Qing Li, et al.. (2022). Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population. Chinese Medical Journal. 135(14). 1734–1741. 4 indexed citations
13.
Yuan, Peng, Miao Liu, Xianan Li, et al.. (2021). Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study. World Journal of Surgical Oncology. 19(1). 6 indexed citations
14.
Yuan, Peng, et al.. (2020). Circular RNA hsa_circ_0068033 Acts as a Diagnostic Biomarker and Suppresses the Progression of Breast Cancer Through Sponging miR-659. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Yang, Houpu, Fei Xie, Fuzhong Tong, et al.. (2019). Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer. Journal of Surgical Oncology. 120(4). 587–592. 8 indexed citations
16.
Yuan, Peng, et al.. (2019). Fluoxetine Attenuated Anxiety-Like Behaviors in Streptozotocin-Induced Diabetic Mice by Mitigating the Inflammation. Mediators of Inflammation. 2019. 1–8. 21 indexed citations
17.
Yuan, Peng, Lijun Di, Xiaohui Zhang, et al.. (2015). Efficacy of Oral Etoposide in Pretreated Metastatic Breast Cancer. Medicine. 94(17). e774–e774. 16 indexed citations
18.
Zhang, Tongtong, Qing Li, Binghe Xu, et al.. (2014). [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].. PubMed. 36(9). 697–702. 2 indexed citations
19.
Yu, Dianke, Xuemei Zhang, Ju Liu, et al.. (2008). Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis. Clinical Cancer Research. 14(9). 2878–2886. 44 indexed citations
20.
Yuan, Peng, et al.. (2003). [Serum her-2/neu level and related factors in patients with breast cancer].. PubMed. 25(6). 573–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizio Di Bonito Breakdown of academic impact, for papers by Julia Beretov Breakdown of academic impact, for papers by Lisha Qi Breakdown of academic impact, for papers by Michael S. Toss Breakdown of academic impact, for papers by Giosuè Scognamiglio Breakdown of academic impact, for papers by Christina Yau Breakdown of academic impact, for papers by Pascal Jézéquel Breakdown of academic impact, for papers by Yan Mao Breakdown of academic impact, for papers by David A. Quigley
Rankless by CCL
2026